Navigation Links
No Foul Play, Woolmer Died of Naural Causes, Say Jamaican Police

Woolmer, 58, died after being found unconscious in his Kingston hotel room on 18 March, after Pakistan lost to Ireland in the cricket World Cup . An initial pathologist's report had concluded that he had been strangled. Every member of the Pakistan team was fingerprinted before returning home, sparking anger among many in Pakistan.

Jamaican Police Commissioner Lucius Thomas on Monday told a news conference that three different expert opinions had concluded that the original pathologist report of death by manual asphyxiation was wrong.

He also said that toxicology tests had now been received and that they showed there was no substance to indicate poisoning. "The police have now closed the investigation into the death of Bob Woolmer," Thomas said. He launched a strong defence of the police investigation, saying it had been commended by both Scotland Yard and Pakistani police who had helped with the case.

Mr Woolmer's widow, Gill, said: "My sons and I are relieved to be officially informed that Bob died of natural causes and that no foul play is suspected in his death." Mr Woolmer's death sparked speculation he had been murdered by an angry fan or by an illegal betting syndicate. There was also speculation members of the Pakistan team may have been involved.

Mr Thomas said the Jamaica Constabulary Force had found no evidence "of any impropriety by players, match officials nor management". He said the force had carried out its investigation thoroughly and with respect to the Pakistan cricket team. But Pakistan's former captain Imran Khan said he was shocked there was no apology to the national side.

He said Pakistan's cricket board should sue those responsible for the "humiliation that the Pakistan team went through". "Bob Woolmer had diabetes, he had blood pressure, an enlarged heart, he had respiratory problems. On top of it, the depression of losing and then he drank a bottle of champagne. They sho
'"/>




Page: 1 2

Related medicine news :

1. Late Diagnoses of HIV Infected Children is No Child’s Play, Survey Reveal
2. Bob Woolmer Might Have Died of Accidental Drug and Alcohol Overdose
3. Woolmer’s Death Suspicious, Say Jamaican Polic
4. Bone in Woolmer’s Neck Found Broken, Say Police Source
5. Bob Woolmer Was Strangled With A Towel
6. The Plot Gets Thicker In The Woolmer Case
7. Policemen face trouble fighting malaria
8. CMHA Calls For Better Trained Police For Dealing With The Mentally Ill
9. Police should work as Mental Health Workers
10. BEST Employees And City Policemen Seek HIV/AIDS Treatment
11. Police Look For Clues Near Gas Stations In Teen Killing
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...sure levels that tend to be slightly elevated but ...d high-normal--are at increased risk for suffering...aken in two numbers. The systolic value i.e., the ...resents the pressure in the heart during contracti...
...trol pills should be mindful of the possible inter...ions recommended by the Federal Centers for Diseas...he CDC recently recommended that antibiotic and an...ine, and penicillin, be used to treat those believ...
...through, a team of scientists have successfully tr...e to the diseased one, bringing light to the peopl...ning the current excitement about stem cells, in a...uch as chemical burns, allergic reactions to drug ...
...n acrylic cement mend fractures linked to osteopor...the University of California have been looking at ...res in 90 elderly patients with osteoporosis. They...a - a procedure formerly done during surgery. Two ...
Other Medicine News:
(Date:9/3/2008)...ease Awareness Month, CHARLOTTESVILLE, Va., Sept....a clinical-stage drug-development company commerci...al needs, announced today that it has begun,to enr... lead drug,candidate trans sodium crocetinate (TSC...altrials.gov Website, is investigating TSC as a tr...
(Date:9/3/2008)...- Panacea Pharmaceuticals,Inc. today announced th...g,antibodies against human aspartyl (asparaginyl) ...r biomarker and therapeutic target. These antibodi...husetts Institute of,Technology (MIT) and Panacea ... development of human cancer diagnostics and thera...
(Date:9/3/2008)...lans with FDA, PRINCETON, N.J., Sept. 3 /PRNewswi...hat it successfully completed two key clinical tri...ative low-dose, once-weekly,contraceptive patch, ...t,code AG-200-15. The Phase 2b safety and efficacy...ulation suppression, cycle control and safety. The...
(Date:9/3/2008)...nce Pycnogenol(R) Lowers Joint, Pain, Symptoms; Ma...ation of the Extract, ...to the Center for,Disease Control (CDC), osteoarth...e rise. A new study published in the August journa... bark extract from the French maritime pine,tree, ...
Breaking Medicine Technology:Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Romark Laboratories Completes Enrollment in U S Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non Responders 2156 1Romark Laboratories Completes Enrollment in U S Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non Responders 2156 2Romark Laboratories Completes Enrollment in U S Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non Responders 2156 3Iraq war service 3A A risk factor for bronchiolitis 3F 19967 1Iraq war service 3A A risk factor for bronchiolitis 3F 19967 2Figure Skater Peggy Fleming Teams With HealthSaver 3A Fit for Summer 19965 1Figure Skater Peggy Fleming Teams With HealthSaver 3A Fit for Summer 19965 2Figure Skater Peggy Fleming Teams With HealthSaver 3A Fit for Summer 19965 3Figure Skater Peggy Fleming Teams With HealthSaver 3A Fit for Summer 19965 4Figure Skater Peggy Fleming Teams With HealthSaver 3A Fit for Summer 19965 5New Anticoagulation Management Software Helps Clinics Enhance Efficiency and Improve Patient Safety 19962 1New Anticoagulation Management Software Helps Clinics Enhance Efficiency and Improve Patient Safety 19962 2
... WIRE)--May 1, 2007 - Teva,Pharmaceutical Industri... data from a 36-week, randomized, double-blind,pl... an oral 0.6 mg,dose of laquinimod given daily sig...) disease activity by 38 percent in RRMS,patients ...avorable,trend towards reducing annual relapse rat...
...isease Activity as Measured,by MRI and Relapse --...nc.,(NYSE: DNA) and Biogen Idec, Inc. (Nasdaq: BII...inical study of Rituxan®,(rituximab) in patien...MS) were presented today at the American Academy o... is a therapeutic antibody,that targets and select...
Other Medicine Technology:Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 3Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 4Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 6
Vannas Capsulotomy scissors angled on flat
Vannas Capsulotomy scissors angled to side
Gills-Vannas Capsulotomy scissors straight
Vannas Capsulotomy scissors straight
Medicine Products: